Results 221 to 230 of about 3,159,504 (378)
Act1 Adaptor Protein Is an Immediate and Essential Signaling Component of Interleukin-17 Receptor [PDF]
Seon Hee Chang, Heon Park, Chen Dong
openalex +1 more source
An Off‐the‐Shelf Artificial Proregenerative Macrophage for Pressure Ulcer Treatment
Artificial macrophages (artM) by encapsulating M2 lysates into biodegradable PLGA microspheres and coated with macrophage membrane, are engineered as new therapeutics against skin pressure ulcer. In mouse models, the artM exhibited robust tissue repair through cell recruitment and microenvironment modulation, showing great therapeutic potential for ...
Qi Su+12 more
wiley +1 more source
The role of interleukin-17 in inflammation-related cancers. [PDF]
Zhang X+6 more
europepmc +1 more source
Baicalin alleviates E. coli‐induced intestinal inflammation through dual mechanisms: direct inhibition of the TLR4/IRF/STAT signaling pathway to modulate macrophage polarization and antigen presentation, thereby regulating Th17/Treg cell differentiation; and microbiota‐mediated indirect effects via increasing Lactobacillus amylovorus abundance and ...
Shunfen Zhang+10 more
wiley +1 more source
Interleukin-17 Inhibitors in the Treatment of Hidradenitis Suppurativa. [PDF]
Pinto Salgueiro G+3 more
europepmc +1 more source
Case report: Interleukin-17 targeted biological therapy in netherton syndrome. [PDF]
Mahajan R+4 more
europepmc +1 more source
Association analysis of the interleukin 17 genes IL17A and IL17F as potential osteoarthritis susceptibility loci [PDF]
Lorraine Southam
openalex +1 more source
Glycolysis‐derived lactate activates nucleus pulposus cell ferroptosis via Histon H3K18la‐mediated ACSL4 transcription and ACSL4 lactylation and aggravate intervertebral disc degeneration. Inhibiting glycolysis via gene silencing or chemical intervention reduces the production of lactate and ameliorates ferroptosis activation and nucleus pulposus ...
Kaiqiang Sun+10 more
wiley +1 more source
Abstract Direct comparisons of the effectiveness of the numerous novel therapies in the diffuse large B‐cell lymphoma (DLBCL) treatment landscape in a range of head‐to‐head randomized phase 3 trials would be time‐consuming and costly. Comparative effectiveness studies using real‐world data (RWD) represent a complementary approach.
Grzegorz Nowakowski+4 more
wiley +1 more source